Lancet (original) (raw)

Latest News for: lancet

Edit

Israeli doctors blast 'Lancet' article calling for expulsion from world body

Cleveland Jewish News 15 Jun 2026

Israeli Medical Association terms the article a “cynical politicization of medicine and health.” ... .

Edit

The Lancet publishes call to suspend Israeli Medical Association from global medical body

Virtual Jerusalem 14 Jun 2026

The World Medical Association however told The Lancet that it ...

Edit

For Decades Everyone Believed Yo-Yo Dieting Wrecked Metabolism but New Study Says It’s Not True

The News & Observer 12 Jun 2026

A major new Lancet study is overturning one of the biggest beliefs in diet culture about yo-yo dieting and your metabolism ....

Edit

South Asian Women Face Higher Risk Of Premature Menopause: Lancet Study

NDTV 10 Jun 2026

Women in low and middle-income countries could be at a 53 per cent increased risk of a premature menopause, with half of them reaching menopause by age 47.5 years, compared with age 50.6 years in... .

Edit

Ghana-Africa Business Awards honour businesses driving intra-African trade

B & FT Online 09 Jun 2026

MDS-Lancet Laboratories Ghana Ltd ... Richard Duah Nsenkyire, Managing Director of Samartex Timber & Plywood Limited Company, and Dr Paul Sekyere-Nyantakyi, Chief Executive Officer of MDS-Lancet ...

Edit

Data Published in The Lancet Explores Potential Risk Reduction with KERENDIA® (finerenone) for Adults with Chronic Kidney Disease, With or Without Type 2 Diabetes (Bayer Corporation)

Public Technologies 05 Jun 2026

The Lancet published initial results from the INFINITY prespecified exploratory pooled ... an individual participant data pooled analysis (INFINITY)," is available on the website of The Lancet.

Edit

Novartis IgAN data in The Lancet show clinically meaningful slowing of kidney function decline with ...

Nasdaq Globe Newswire 04 Jun 2026

Results were published in The Lancet and presented at the European Renal Association (ERA) Congress ... “They highlight the role of a highly selective endothelin A receptor antagonist as part of an evolving treatment approach for IgAN.” .

Edit

Wits kidney disease expert brings African perspective to landmark Lancet papers (University of the Witwatersrand)

Public Technologies 04 Jun 2026

) Wits kidney disease expert brings African perspective to landmark Lancet papers ... Wits University, who is the only contributor from Africa to a landmark Lancet series on chronic kidney disease (CKD).

Edit

Candel Therapeutics Announces Publication in The Lancet Oncology of Pivotal Phase 3 Data

Hastings Tribune 02 Jun 2026

Peer reviewed publication details pivotal data, demonstrating 30% ...

Edit

Candel Therapeutics Announces Publication in The Lancet Oncology of Pivotal Phase 3 Data Demonstrating Significant ...

Nasdaq Globe Newswire 02 Jun 2026

... in December 2024, in The Lancet Oncology, one of the world’s leading peer-reviewed oncology journals (impact factor 35.9).

Edit

UCB and Biogen Announce Publication in The Lancet of Positive Dapirolizumab Pegol (DZP) Phase 3 ...

Nasdaq Globe Newswire 01 Jun 2026

BIIB) today announced that�The Lancet, a world-leading medical journal, has published the full results from the Phase 3 ...

Edit

UCB and Biogen Announce Publication in The Lancet of Positive Dapirolizumab Pegol (DZP) Phase 3 Study Results in Systemic Lupus Erythematosus (Biogen Inc)

Public Technologies 01 Jun 2026

UCB and Biogen Announce Publication in The Lancet of Positive Dapirolizumab Pegol (DZP) Phase 3 Study Results in Systemic Lupus Erythematosus ... BIIB) today announced that The Lancet, a ... Lancet.

Edit

UCB and Biogen Announce Publication in The Lancet of Positive Dapirolizumab Pegol (DZP) Phase 3 Study Results in Systemic Lupus Erythematosus (UCB SA)

Public Technologies 01 Jun 2026

) UCB and Biogen Announce Publication in The Lancet of Positive Dapirolizumab Pegol (DZP) Phase 3 Study Results in Systemic Lupus Erythematosus ... BIIB) today announced that The Lancet, a ... Lancet.

Edit

Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab for First-Line Treatment of PD-L1-Positive NSCLC Published in The Lancet

PR Newswire 31 May 2026

The publication of these findings in The Lancet further signifies that the clinical and academic value of this combination therapy has received internationally recognized validation.

Edit

Blood Test Can Help Detect Alzheimer's Signs Decades Before Symptoms: Lancet

NDTV 30 May 2026

The findings demonstrate the potential of detecting early-stage AD among middle-aged adults using blood tests ... .